BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.2% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
e.l.f. Beauty
ELF
$5.45B
| $55.7K | ﹤0.01% |
5,253
+4,707
| +862% | +$42K |
|
|
LCI
3327
DELISTED
Lannett Company, Inc.
LCI
| $55.5K | ﹤0.01% |
1,762
+904
| +105% | +$29.1K |
|
|
CNR
3328
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $55.4K | ﹤0.01% |
8,993
+8,244
| +1,101% | +$60.5K |
|
3329
Business First Bancshares
BFST
$1.05B
| $55.4K | ﹤0.01% |
2,257
+1,832
| +431% | +$44.1K |
|
3330
Lexicon Pharmaceuticals
LXRX
$1.05B
| $55.2K | ﹤0.01% |
9,934
+8,979
| +940% | +$54.5K |
|
|
KDMN
3331
DELISTED
Kadmon Holdings, Inc.
KDMN
| $55.1K | ﹤0.01% |
+20,856
| New | +$52.6K |
|
|
TGH
3332
DELISTED
Textainer Group Holdings limited
TGH
| $54.9K | ﹤0.01% |
5,691
+3,377
| +146% | +$40.1K |
|
|
ONIT
3333
Onity Group
ONIT
$326M
| $54.9K | ﹤0.01% |
2,010
+949
| +89% | +$26.7K |
|
|
ELOX
3334
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $54.6K | ﹤0.01% |
+117
| New | +$56.8K |
|
3335
Home Bancorp
HBCP
$570M
| $54.4K | ﹤0.01% |
1,637
+1,372
| +518% | +$48.7K |
|
|
PYX
3336
DELISTED
Pyxus International, Inc.
PYX
| $54.4K | ﹤0.01% |
2,277
+719
| +46% | +$15K |
|
3337
RBB Bancorp
RBB
$463M
| $54.3K | ﹤0.01% |
2,886
+2,450
| +562% | +$48.3K |
|
|
KDNY
3338
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $54.3K | ﹤0.01% |
2,726
+2,600
| +2,063% | +$45.3K |
|
|
GDEN
3339
DELISTED
Golden Entertainment
GDEN
| $54.2K | ﹤0.01% |
+3,827
| New | +$67K |
|
|
MCBC
3340
DELISTED
Macatawa Bank Corp
MCBC
| $54.1K | ﹤0.01% |
5,446
+4,687
| +618% | +$47.7K |
|
|
HMTV
3341
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $54.1K | ﹤0.01% |
3,837
+3,526
| +1,134% | +$47.1K |
|
3342
Costamare
CMRE
$1.74B
| $54K | ﹤0.01% |
10,382
+8,560
| +470% | +$43.1K |
|
3343
CALL
Northrop Grumman
NOC
$81.6B
| $53.9K | ﹤0.01% |
2
-6
| -75% | -$1.64K |
|
3344
British American Tobacco
BTI
$124B
| $53.9K | ﹤0.01% |
1,292
+149
| +13% | +$5.42K |
|
|
BRG
3345
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $53.8K | ﹤0.01% |
4,993
+4,192
| +523% | +$43.7K |
|
3346
Blue Bird Corp
BLBD
$2.06B
| $53.7K | ﹤0.01% |
3,174
+2,857
| +901% | +$53.6K |
|
|
CNCE
3347
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $53.5K | ﹤0.01% |
4,431
+4,424
| +63,200% | +$65.2K |
|
3348
Global Indemnity Group
GBLI
$409M
| $53.4K | ﹤0.01% |
1,759
+1,527
| +658% | +$53.3K |
|
3349
Hurco Companies Inc
HURC
$143M
| $53.1K | ﹤0.01% |
1,316
+1,104
| +521% | +$43.7K |
|
3350
First Bancorp
FNLC
$402M
| $53K | ﹤0.01% |
2,126
+1,779
| +513% | +$46.6K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.